Synonyms: CL-297939 | EMD-33512 | Zebeta®
bisoprolol is an approved drug (FDA (1992))
Compound class:
Synthetic organic
Comment: Bisoprolol is a β-blocker, selective for β1-adrenoceptors in cardiac tissue. The S(-) enantiomer is believed to account for most of its β-blocking activity.
Marketed formulations may contain bisoprolol fumarate (PubChem CID 6917733). Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖View more information in the IUPHAR Pharmacology Education Project: bisoprolol |
|
No information available. |
Summary of Clinical Use |
Used to treat hypertension, stable chronic angina and specific forms of stable chronic heart failure. |
Mechanism Of Action and Pharmacodynamic Effects |
Bisoprolol blocks catecholamine stimulation of β1-adrenoceptors in the heart to lower the heart rate and blood pressure. |
External links |
For extended ADME data see the following: Electronic Medicines Compendium (eMC) Drugs.com |